Evaluation of albendazole efficiency and complications in patients with pulmonary hydatid cyst.

Autor:	Aydin Y; Department of Thoracic Surgery, Faculty of Medicine, Ataturk University, Erzurum, Turkey.; Anesthesiology Clinical Research Office, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Ulas AB; Department of Thoracic Surgery, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Ince I; Anesthesiology Clinical Research Office, Faculty of Medicine, Ataturk University, Erzurum, Turkey.; Department of Anesthesiology and Reanimation, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Kalin A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Can FK; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Gundogdu B; Department of Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Kasali K; Department of Bioistatistics, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Kerget B; Department of Pulmonary Diseases, Faculty of Medicine, Ataturk University, Erzurum, Turkey., Ogul Y; Department of Medicinal Biochemistry, Regional Training and Research Hospital, Health Sciences University, Erzurum, Turkey., Eroglu A; Department of Thoracic Surgery, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Jazyk:	angličtina
Zdroj:	Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2022 Jan 18; Vol. 34 (2), pp. 245-249.
DOI:	10.1093/icvts/ivab259
Abstrakt:	Objectives: This study investigated the efficacy and complications of albendazole use after surgery in patients with pulmonary hydatid cysts. Methods: One hundred fifty-three consecutive patients who met the study criteria out of 215 patients who received prophylaxis with albendazole after surgery for isolated pulmonary hydatid cysts in our clinic between January 2011 and December 2020 were analysed retrospectively. Results: Eighty-six out of 153 (56.2%) of cases were male and 67 (43.8%) were female. The average age was 24.6 ± 17.4 (between 3 and 71 years), 76 of them (49.7%) were 18 years old and younger, while 77 (50.3%) were adults. All cases were approached transthoracically and a total of 170 operations were performed on the 153 cases. Fever, weakness and dizziness were reported in only one patient who was given albendazole treatment. A partial increase in liver enzymes was observed in 16 cases (10.5%) after albendazole treatment. Mild leukopoenia and neutropenia were observed in only one of the cases. In 1 case, a second operation was performed 30 months later due to recurrence. Albendazole treatment was not required to be discontinued in any of the cases. Mortality was not observed in any of the cases. Factors such as mean age, cyst size and hospitalization period did not have a statistically significant effect on any changes in liver enzymes tests following albendazole therapy (P > 0.05). Conclusions: Albendazole treatment can safely be used for postoperative prophylaxis in patients with pulmonary hydatid cysts in a controlled manner without causing serious complications. Subj Collection: 152. (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu